Genç nüfusuna rağmen AB ve ABD'de olduğu gibi ülkemizde de koroner arter hastalığı (KAH) önde gelen ölüm sebebidir. Ayrıca ülkemizde KAH prevalansı giderek artmaktadır. Bu nedenle sağlık sisteminin hem klinik sonuçları, hem de sağlık ekonomisi açısından KAH ile daha yakından ilgilenmesi zorunluluk kazanmaktadır. Bu çalışma böyle bir değerlendirmeye olanak sağlamak üzere derlenmiştir. Bu amaçla kararlı KAH hastalarında ilk adım tanı stratejilerinin klinik ve maliyet etkinlikleri, güncel tedavi stratejileri ile birlikte ele alınmıştır. Anahtar Kelimeler: Koroner arter hastalığı, maliyet-fayda analizi, miyokard perfüzyon görüntülenmesi, koroner anjiyografi Despite its younger population, coronary artery disease (CAD) is the leading cause of death in Turkey, as it is in Europe and the United States. The prevalence of CAD in our country increases steadily. So, the healthcare system must take care of the economic consequences of the disease as much as its clinical results. This overview was written to enable such an evaluation. For this reason, the prognostic outcomes and cost-effectiveness of the initial diagnostic strategies in stable CAD were assessed together with new insights in treatment strategies

A 61-year-old man with carcinoma of the right lung was admitted because of dyspnea. Thoracic computed tomography (CT) showed right upper lobe atelectasis. A Tc-99m methylene diphosphonate (MDP) bone scan was performed to rule out metastases. Increased Tc-99m MDP soft tissue uptake was seen in the right upper hemithorax. Tc-99m MIBI scintigraphy of this area was negative. Since there was no pathologic Tc-99m MIBI accumulation and no evidence of tumor on the CT scan in the right upper lobe, the increased Tc-99m MDP uptake was at the site of the atelectasis.

No abstract

No abstract